Literature DB >> 3536910

Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains.

L J Fretto, W E Fowler, D R McCaslin, H P Erickson, P A McKee.   

Abstract

The effects of Staphylococcus aureus V8 protease (V8) on the multimeric structure of human von Willebrand factor (vWF) were studied to test and expand our model for the substructure of vWF. Electron microscopy of V8 digests of vWF revealed that the multimers were cleaved where the flexible rod (R) domains join the large elongated globular (G) domains. The resulting two major fragments, which were purified by affinity and hydrophobic interaction chromatography and by glycerol-gradient ultracentrifugation, are disulfide-linked homodimers of these domains (i.e. RR and GG) and are morphologically identical to the alternating RR and GG domains of intact vWF. The glycoprotein fragment GG (6.5 X 35 nm) has mass 343 kDa by sedimentation equilibrium and the amino-terminal sequence of intact plasma vWF. It contains the binding site for heparin within 300 residues of its amino terminus and a separate site for the platelet GPIb receptor responsible for platelet agglutination in the presence of ristocetin. With approximately 18% alpha-helix and approximately 15% beta-pleated sheet, fragment GG accounts for most of the ordered secondary structure present in whole vWF. The two thin flexible rod domains (1.8-2.0 X 30-34 nm) of fragment RR are joined at a small central nodule (approximately 5 nm diameter) and also have a small nodule at each free end. Fragment RR contains an extraordinarily high cystine content, lower than average amounts of other hydrophobic residues, and essentially no alpha-helix, as judged by circular dichroism. The amino-terminal sequence and amino acid composition of fragment RR corresponded to that of the COOH-terminal 685 residues of the intact vWF subunit (Titani, K., Kumar, S., Takio, K., Ericsson, L. H., Wade, R. D., Ashida, K., Walsh, K. A., Chopek, M. W., Sadler, J. E., and Fujikawa, K. (1986) Biochemistry 25, 3171-3184). This sequence analysis gives a mass of 180 kDa for glycosylated fragment RR, somewhat higher than the 130 kDa we obtained by sedimentation equilibrium. Our sequence analysis of a 110-kDa plasmic vWF peptide also permitted identification of a major plasmin cleavage site 705 residues from the COOH terminus and a half-cystine residue (1360) involved in maintaining the multimeric structure of plasmin-degraded vWF.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536910

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.

Authors:  R Schneppenheim; J Brassard; S Krey; U Budde; T J Kunicki; L Holmberg; J Ware; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

2.  A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.

Authors:  I Tornai; J Arnout; H Deckmyn; K Peerlinck; J Vermylen
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

3.  Heparin Binding Sites Are Located in a 40-kD gamma-Chain and a 36-kD beta-Chain Fragment Isolated from Human Fibrinogen.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

4.  Fluid shear induces conformation change in human blood protein von Willebrand factor in solution.

Authors:  Indrajeet Singh; Efrosyni Themistou; Lionel Porcar; Sriram Neelamegham
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

Review 5.  Acquired von Willebrand syndrome associated with left ventricular assist device.

Authors:  Angelo Nascimbene; Sriram Neelamegham; O H Frazier; Joel L Moake; Jing-Fei Dong
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

6.  Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor.

Authors:  Emma-Ruoqi Xu; Sören von Bülow; Po-Chia Chen; Peter J Lenting; Katra Kolšek; Camilo Aponte-Santamaría; Bernd Simon; Jaelle Foot; Tobias Obser; Reinhard Schneppenheim; Frauke Gräter; Cécile V Denis; Matthias Wilmanns; Janosch Hennig
Journal:  Blood       Date:  2018-10-10       Impact factor: 22.113

7.  von Willebrand factor antigen compared with other factors in vasculitic syndromes.

Authors:  E Ateş; A Bakkaloğlu; U Saatçi; O Söylemezoğlu
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

Review 8.  Platelet adhesion under flow.

Authors:  Zaverio M Ruggeri
Journal:  Microcirculation       Date:  2009-01       Impact factor: 2.628

9.  Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization.

Authors:  J Voorberg; R Fontijn; J A van Mourik; H Pannekoek
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

10.  Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro-polypeptide in vWF multimer formation.

Authors:  C L Verweij; M Hart; H Pannekoek
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.